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Volume 49, Number 5S Poster Presentations 23SResults: A total of 170 patients (95 males / 75 females) with a mean
age of 55  1 years were implanted. With both unilateral and bilateral
stimulation, there were significant intra-operative decreases in both systolic
and diastolic BP, along with HR. These therapeutic results were maintained
at one year follow-up (n49) at which time a large percentage of patients
(53%) were being treated unilaterally and there were no differences in results
between unilateral and bilateral stimulation:
SBP (mmHg) DBP (mmHg) HR (bpm)
Baseline 181  2 104  1 75  1
Intra-Operative (vs
Baseline)
Unilateral 32  2* 17  1*# 11  1*#
Bilateral 34  2* 18  1* 8  1*
One Year Follow-Up
(vs Baseline)
Unilateral 24  5* 15  3* 8  2*
Bilateral 19  8* 12  4* 7  2*
*p  0.01 vs Baseline.
#p0.05 vs. Bilateral.
Two-year follow-up data (n32) indicated a sustained systolic BP reduction
of 23  6 mmHg [p  0.001 vs. baseline].
Conclusions: Baroreceptor stimulation has sustained efficacy in de-
creasing both systolic and diastolic blood pressure in patients with resistant
hypertension. Similar results were attained with unilateral stimulation sug-
gesting single-sided implantation may be an acceptable clinical alternative in
the future.
Author Disclosures: J. Blebea, CVRx; C. Kaufman, CVRx.
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The Forgotten Pectoralis Minor Syndrome: Report of 100 Operations
Richard J Sanders1,2, Neal M Rao3. 1University of Colorado, Denver, CO;
2Rose Medical Center, Denver, CO; 3UCLA, Los Angles, CA
Objective: Pectoralis minor syndrome (PMS), first described in 1945,
is another cause of pain and paresthesia in the upper extremity. Its symptoms
mimick thoracic outlet syndrome (TOS). Between 2005 and 2007, more
than 75% of patients referred to us for TOS were found to have PMS, either
alone or combinated with TOS. We report 100 PM tenotomy operations in
these patients.
Methods: There were 100 pectoralis minor (PM) tenotomies per-
formed as the only procedure in 76 patients (24 bilateral). Diagnosis was
made by history of pain or tenderness below the clavicle and in the axilla plus
physical findings of tenderness over the PM tendon. Other common symp-
toms were upper extremity pain, paresthesia, and weakness, similar to
symptoms found in TOS. Diagnosis was confirmed by a positive response to
a PM muscle block with lidocaine. PM tenotomy was performed as an
outpatient under local anesthesia with heavy sedation through a 5-7 cm
transaxillary incision.
Results:History and physical exam separated patients into two groups:
52 operations for PMS alone; 48 for combined PMS and TOS. Symptoms
common to both groups were paresthesia and pain in upper extremity and
anterior chest wall (p0.05). Symptoms of occipital headache, neck and
supraclavicular pain were present in 81-96% of the combined group but only
31-50% of the PM-alone group and were much milder in the later group
(p.001). PM tenderness was present in almost all patients in both groups,
but positive responses to TOS provocative maneuvers were milder and less
frequent in the PM-alone group (p.008). 1-3 year success rates for
PM-alone were 81% good-excellent, 11% fair, and 8% failed; for PMS&TOS
group results were 31% good-excellent, 19% fair, and 50% failed. The only
complications were three wound infections. Most patients returned to work
within a few days. Subsequently thoracic outlet decompression was per-
formed in 62% of failed patients in the PMS&TOS group.
Conclusion: PMS should be considered in all patients presenting with
symptoms of TOS. The importance of recognizing PMS is that many of
these patients can be successfully treated with a relatively risk-free procedure
thereby avoidingmore invasive thoracic outlet operations and their potential
complications. When PMS accompanies TOS the two can be operated upon
simultaneously.Author Disclosures: R.J. Sanders, None; N.M. Rao, None.Lower Extremity Revascularization: Endo and Open
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Does Nitinol Stent Design Influence Long-term Patency and Integrity
in Long Femoro-popliteal Occlusions?
Massimo Lenti1, Enrico Cieri1, Paola De Rango1, Giacomo Isernia1, Paolo
Bonanno1, Mathias Fischer2, Piergiorgio Cao1. 1Vascular and Endovascular
Surgery Unit,University of Perugia, Perugia, Italy; 2Interventional Radiol-
ogy Unit,University of Perugia, Perugia, Italy
Background: Changes in nitinol stent design and conformation have
been introduced to increase radial force and avoid loss of integrity in
femoro-popliteal (F-P) occlusions.
Objective: To compare long-term patency and frequency of fractures
in different nitinol F-P stents.
Methods: Two Groups of nitinol F-P stent were compared: Group I,
continuous elicoidal covered (ePTFE) stent and Group II, bare no-spiral
stents. All stents implanted for F-P obstruction in 2001-2008 were re-
viewed. Patency was investigated by duplex ultrasound and Stent integrity
using double projection x-ray with high-resolution images with Extended
and flexed leg position. The association between fractures and patency,
timing from implantation, calcification, lesion length and patients’ charac-
teristic was compared.
Results: A total of 102 F-P lesions were stented (mean age 70.6years,
males 66%): 59 inGroup I and 43 inGroup II. The 2Groups were similar for
baseline characteristics, lesion morphology and indications. Mean lesion
length was 132mm (IQR 80-180). At 32 months, assisted patency was 68%,
without no differences between II Groups. Sixty-nine patients were available
for stent integrity analysis. Twenty-five (36%) stent fractures were detected,
more frequent in Group I (20/41; 49%) than in Group II (5/28; 18%), 95%
CI 1.39-13.8; OR 4.3,p0.01. Overall, 15 (21.7%) fractured stents were
still patent. In patients available for stent integrity, assisted patency rate at 32
months was 73% in Group I vs 65% Group II (p0.88) . Logistic regression
showed that longer lesions (HR 1.11; 95% CI1.00-1.024; p 0.013) were the
only strongly negative predictors of patency in Group II while, failed to
confirm any statistically association between length of lesion and patency in
Group I.
Conclusion: Different design in F-P stents, spiral or not, offers the
same patency in mid and long term. Nevertheless, spiral stent deals better in
longer lesions but the high radial force increasing the fracture rate is a major
concern. Further design research and improvement of material resistance are
required to achieve satisfactory long-term results in F-P area.
Author Disclosures: M. Lenti, None; E. Cieri, None; P. De Rango,
None; G. Isernia, None; P. Bonanno, None; M. Fischer, None; P. Cao,
None.
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Midterm Results with Endovascular Popliteal Artery Aneurysm Repair
with ePTFE Covered Stent Grafts
Hiranya A Rajasinghe1,2,3, Santiago H Chahwan1,2,3, Argyrios Tzilinis1,2,3.
1Vascular and Endovascular Surgery, Anchor Health Centers, PA, Naples,
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Objective: Early success has been demonstrated with endovascular
repair for popliteal artery aneurysms (PAA) with the Viabahn endoprosthe-
sis. This purpose of this report is to assess the midterm results of endovas-
cular PAA repair with ePTFE covered stent grafts.
Methods: From June 2004 to January 2009, 40 patients (mean age 75
years) underwent endovascular repair of 52 PAAs (mean diameter 2.5 cm).
Patients with contraindications to antiplatelet or anticoagulant therapy, no
in-line tibial artery runoff, and acute limb ischemia were excluded. Proce-
dures were performed under local anesthesia using ipsilateral percutaneous
antegrade arterial access. All patients received 75 mg/day of clopidogrel
afterwards. Follow-up assessments included direct clinical examination and
duplex ultrasonography performed at yearly intervals after the procedure.
Patency, secondary patency, freedom from reintervention, limb salvage, and
late complications were assessed.
Results: Mean and median follow-up were 25 and 23 months, respec-
tively (range 1 - 49). Reintervention rate was 19% but no reinterventions
have been performed beyond 18 months of follow-up. No stent-graft
thromboses occurred beyond 8 months follow-up. No limb loss was ob-
served.
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exclusion of asymptomatic popliteal artery aneurysms are promising with few
complications and continue to match historical results with surgical arterial
reconstruction.
Author Disclosures: H.A. Rajasinghe, None; S.H. Chahwan, None; A.
Tzilinis, None.
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Contemporary Management of Critical Lower Limb Ischaemia (CLI)
with TASC C and D femoro-popliteal lesions. 5-year Comparative
Trial of Subintimal Angioplasty (SIA) or Bypass surgery (BS)
Sherif Sultan, Niamh Hynes. Western Vascular Institute, Galway, Ireland
CLI patients face a dismal prognosis with one year mortality up to 30%
Infra-popliteal BS is a demanding procedure with poor long-term survival. A
minimally invasive therapy with equivalent results would be more appropri-
ate. SIA is easy to execute; requires short hospital admission and lower costs.
Primary endpoints are sustained clinical improvement (SCI) and amputation
free survival (AFS). Secondary endpoints are BinaryRrestenosis (BR) rate,
Freedom from target lesion revascularisation (TLR), risk of Major Adverse
Clinical Events (MACE), Quality Time Without Symptoms of disease or
Toxicity of Treatment (Q-TWiST) and cost-effectiveness. From 2002-
2007, 1076 patients were referred with PVD. 334 primary procedures
(SIA206, BS128) in 309 patients (NSIA190, NBS119) with TASC
C and D lesions were prospectively compared Mean age (SIA 73/13yrs
vs. BS 70/14yrs, p0.127), and co-morbidity severity scores (P0.05)
were similar between groups. 5-year SCI was 82.8% for SIA and 68.2% for
BS ( p0.106 h0.65, 95%CI[0.38-1.11]). 5-year all-cause survival was
similar for SIA (78.6%) and BS (80.1%), p0.7343. 5-year AFS was com-
parable (SIA 72.9% vs. BS 71.2%, p0.9765). Hyper-fibrinogenaemia and
elevated CRP had negative effect on AFS (p0.009, RR2.4, 95%CI1.2-
4.6 and p0.019, RR1.02, 95%CI1.01-1.04, respectively). 5-year free-
dom from BR were (SIA72.8% vs.BS65.3%, p0.7001). Hyper-homocys-
teine had significant adverse effect on risk of BR for SIA (p0.008) and BS
(p0.019) Results were not effected by stent use (35%, p0.780) or mean
number of stents (RR1.3, p0.330). 5-year freedom from TLR was (SIA
85.9% vs. BS 72.1%, p0.262). Risk of MAE (P0.002) and length of
hospital stay (LOSSIA14/16days vs. LOSBS24/23days,
P0.0001) were significantly reduced with SIA. Q-TWiST significantly
improved (P0.001) and cost per QALY (SIA: €5,663 vs BS: €9,172,
P0.05) reduced with SIA. 5-year risk of re-intervention (p0.05) and
mean number of procedures (SIA 1.19 vs. BS 1.10, p0.078) were similar.
BS is an independent risk factor for MACE. 5-year Freedom fromMACE in
SIA is enhanced by 20%. SIA enhances patient-specific Q-TWiST with
substantial cost reduction, is minimally invasive and allows for a high patient
turnover without compromising limb salvage. SIA has caused a Paradigm
Shift in CLI Management.
Author Disclosures: S. Sultan, None; N. Hynes, None.
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Inflow and Outflow Improvement by Endovascular Procedures During
Surgical Revascularization of Lower Limbs.
Gianluca Faggioli, Mauro Gargiulo, Natascia Muccini, Federica Giovanetti,
Antonio Freyrie, Andrea Stella. University of Bologna, Bologna, ItalyBackground: Endovascular revascularization techniques (ERT) are
increasingly performed in the treatment of critical limb ischemia (CLI),
however their role as an adjunct to open surgical revascularizations
(OSR), has been scarcely investigated, particularly as a method to im-
prove outflow. We have evaluated early and long-term results of CLI
revascularization obtained by OSR with either proximal or distal simul-
taneous ERT.
Methods: A series of consecutive patients undergoing simultaneous
OSR and ERT for CLI have been prospectively evaluated. Cases were
divided into three groups: GI: inflow procedures - ERT was performed
proximally to the proximal anastomosis of OSR; GII combined proce-
dures - profundoplasty and distal ERT; GIII - proximal OSR and distal
ERT. Choice for simultaneous ERT was made when a sufficient length of
autologous graft was unavailable or in order to significantly reduce the
magnitude of OSR. Results have been evaluated clinically and by duplex
scanning perioperatively and at 3, 6, 12, 18, 24 and 36 months and
calculated by life table analysis. Differences between groups were assessed
by log-rank test.
Results: In a series of 867 treatments for CLI, simultaneous OSR and
ERT were performed in 52 cases (5.9%) (GI: 23 - 44.2%, GII 11 - 21.1%,
and GIII 16 - 30.7%), with perioperative patency of 100%. Follow-up was
available in 50 cases (94%) for a mean of 11.5 8.8months. Overall patency
and survival at 36months were 59.5% and 79.6% respectively (GI: 74.1% and
70.8%, GII 60.6% and 90.9%, GIII 34.4% and 100%, p0.16 and 0.54
between groups).
Conclusions: Regardless of the strategy utilized, ERT are a valuable
adjunct to OSR and may help to minimize the impact of OSR. Early and
long-term results in cases with known unfavourable expectation are encour-
aging. Inflow and outflow ERT have similar impact on results.
Author Disclosures: G. Faggioli, None; M. Gargiulo, None; N. Muc-
cini, None; F. Giovanetti, None; A. Freyrie, None; A. Stella, None.
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Assessment of Self-Expanding Nitinol Stent Deformations Implanted
into the Femoropopliteal Artery
Alexander Nikanorov1, Martin Schillinger2, Hugh Zhao1, Erich Minar2,
Lewis B Schwartz1. 1Abbott Vascular, Santa Clara, CA; 2Medical University
of Vienna, Vienna, Austria
Objectives: Endovascular stenting has emerged as a promising therapy
for femoropopliteal occlusive disease, but stent fractures remain a safety
concern. The aim of this study was to quantify the degree of deformations
encountered by nitinol stents when implanted into patients.
Methods: Patients undergoing femoropopliteal endovascular stenting
were eligible for study. Stent deformations were assessed by measurement of
stent length, deflection angle and bending radius via lateral view radiograms
obtained two days and six months following implantation with the patient in
three positions: neutral standing (knee/hip flexion 0°/0°), simulated am-
bulation (knee/hip flexion 70°/20°) and simulated stair climbing (knee/
hip flexion 90°/90°).
Results: Nineteen stent implantations in seventeen patients were
assessed. Stents were confined to the superficial femoral artery (SFA) in
eleven cases, extended to the proximal popliteal artery (SFA/prox pop)
in two cases (defined as terminating at least 3 cm above the intercondylar
fossa) and crossed the knee joint (popliteal) in six cases. Single stents of
80 or 100 mm length were implanted in sixteen cases; overlapped stents
were required in three cases. Leg flexion was associated with 5-10%
shortening (compression) of the stent, the greatest amount being ob-
served for stents implanted into the popliteal artery (SFA 3.1%1.8%,
SFA/prox pop 5.30.5%, popliteal 8.6%3.2%). Profound stent bend-
ing (deflection angle 64°16°, bending radius 222 mm) was observed
in the popliteal artery, with slight bending in the SFA stents (SFA 5°2°,
13853 mm; SFA/prox pop 8°4°, 5510 mm). Follow-up examina-
tions were performed in fourteen stent implantations of thirteen patients
after a mean follow-up of 7.11.3 months. In these patients, the degree
of stent deformation during leg flexion was essentially unchanged as
compared to immediate post-procedure levels.
Conclusions: In patients with femoropopliteal occlusive disease, in-
dwelling nitinol stents are routinely bent and compressed during leg flexion.
Stent bending is considerably more pronounced after implantation into the
popliteal artery as compared to the SFA. As the observed levels of compres-
sion and bending were unchanged after six months, short-term vascular
remodeling appears to have no effect on stent deformation.
Author Disclosures: A. Nikanorov, Abbott Laboratories; M. Schillinger,
consulting fees; H. Zhao, Abbott Laboratories; E. Minar, consulting fees;
L.B. Schwartz, Abbott Laboratories.
